StonvexLoading…
StonvexStonvexStonvexCore line items from SMXT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $14.83M | $90.98M | $44.41M | $13.81M |
Operating Income | $96.20K | $-6.30M | $-5.03M | $-2.92M |
Net Income | $-306.68K | $-6.33M | $-5.45M | $-3.20M |
EPS (Diluted) | $-0.01 | $-0.13 | $-0.11 | $-0.07 |
Total Assets | $106.19M | $91.29M | $58.66M | $38.24M |
Total Liabilities | $117.60M | $103.50M | $70.44M | $53.35M |
Cash & Equivalents | $4.31M | $7.97M | $5.72M | $1.92M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 56.91M | 54.91M | 54.30M | 48.59M |